Anette Lindqvist
Director of Finance/CFO at XBRANE BIOPHARMA AB
Net worth: 3 568 $ as of 30/04/2024
Anette Lindqvist active positions
Companies | Position | Start | End |
---|---|---|---|
XBRANE BIOPHARMA AB | Director of Finance/CFO | 11/01/2021 | - |
Investor Relations Contact | 11/01/2021 | - | |
Nanolyze AB
Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Chairman | - | - |
Career history of Anette Lindqvist
Former positions of Anette Lindqvist
Companies | Position | Start | End |
---|---|---|---|
MEDIVIR AB | Director/Board Member | 05/05/2022 | 20/10/2023 |
SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
COMBINEDX AB | Director/Board Member | 01/01/2018 | - |
Training of Anette Lindqvist
University of Gothenburg | Undergraduate Degree |
Statistics
International
Sweden | 8 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Director of Finance/CFO | 1 |
Sectoral
Health Technology | 4 |
Commercial Services | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
MEDIVIR AB | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
XBRANE BIOPHARMA AB | Health Technology |
COMBINEDX AB | Commercial Services |
Private companies | 2 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Nanolyze AB
Nanolyze AB Miscellaneous Commercial ServicesCommercial Services Nanolyze AB develops bio analytical technology. The company is based in Mölndal, Sweden. Nils Löfgren has been the CEO of the Swedish company since 2020. | Commercial Services |
- Stock Market
- Insiders
- Anette Lindqvist
- Experience